Thromboprophylaxis with enoxaparin versus unfractionated heparin in elderly patients with acute hip fracture: Survival at eight to ten years.

被引:0
|
作者
Borris, LC
Lassen, MR
Breindahl, M
Jensen, HP
机构
[1] Aarhus Univ Hosp, Dept Orthoped, DK-8000 Aarhus, Denmark
[2] Copenhagen Univ Hosp, Dept Orthoped, Hillerod, Denmark
[3] Aalborg Univ Hosp, Dept Orthoped, Aalborg, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2758
引用
收藏
页码:700A / 700A
页数:1
相关论文
共 38 条
  • [31] Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: The Innohep® in Renal Insufficiency Study (IRIS)
    Leizorovicz, Alain
    Siguret, Virginie
    Mottier, Dominique
    THROMBOSIS RESEARCH, 2011, 128 (01) : 27 - 34
  • [32] Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide
    Goodman, SG
    Fitchett, D
    Armstrong, PW
    Tan, M
    Langer, A
    CIRCULATION, 2003, 107 (02) : 238 - 244
  • [33] Use of reperfusion therapy in patients presenting with ST elevation myocardial infarction: Findings from the TETAMI study and TETAMI registry (the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction)
    Gensini, GF
    Cohen, M
    Maritz, F
    Gurfinkel, EP
    Huber, K
    Timerman, A
    Krzeminska-Pakula, M
    Danchin, N
    White, HD
    Vittori, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 377A - 377A
  • [34] Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)
    Antman, EM
    Morrow, DA
    McCabe, CH
    Jiang, F
    White, HD
    Fox, KAA
    Sharma, D
    Chew, P
    Braunwald, E
    AMERICAN HEART JOURNAL, 2005, 149 (02) : 217 - 226
  • [35] Comparison of bleeding complications and one-year survival of low molecular weight heparin versus unfractioned heparin for acute myocardial infarction in elderly patients. The FAST-MI registry
    Puymirat, Etienne
    Aissaoui, Nadia
    Collet, Jean-Philippe
    Chaib, Aures
    Bonnet, Jean-Louis
    Bataille, Vincent
    Drouet, Elodie
    Mulak, Genevieve
    Ferrieres, Jean
    Blanchard, Didier
    Simon, Tabassome
    Danchin, Nicolas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 166 (01) : 106 - 110
  • [36] Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial
    Fitchett, DH
    Langer, A
    Armstrong, PW
    Tan, M
    Mendelsohn, A
    Goodman, SG
    AMERICAN HEART JOURNAL, 2006, 151 (02) : 373 - 379
  • [37] The basic mobility status upon acute hospital discharge is an independent risk factor for mortality up to 5 years after hip fracture surgery Survival rates of 444 pre-fracture ambulatory patients evaluated with the Cumulated Ambulation Score
    Kristensen, Morten T.
    Kehlet, Henrik
    ACTA ORTHOPAEDICA, 2018, 89 (01) : 47 - 52
  • [38] Impact of low molecular weight heparin on bleeding, need for transfusion and 6-month survival in elderly patients (75 years of age or older) with acute myocardial iinfarction. Data from the FAST-MI registry of the French society of cardiology.
    Durand, Eric
    Schiele, Francois
    Simon, Tabassome
    Godenir, Jean-Philippe
    Cambou, Jean-Pierre
    Tabone, Xavier
    Mulak, Genevive
    Danchin, Nicolas
    CIRCULATION, 2007, 116 (16) : 482 - 482